In July 2014, CMS received a message from the headquarter of the Institutional Investor Magazine. Mr. Lam Kong, CEO of CMS, was awarded as the “All-Asia Best CEO in 2014 from Buy-Side in Healthcare and Pharmaceutical Industry” by the Institutional Investor Magazine for the first time, which ranked the second place; Ms. Yanling Chen, CFO of CMS, was awarded as the “All-Asia Best CFO in 2014 from Buy-Side in Healthcare and Pharmaceutical Industry” by the Institutional Investor Magazine for the third time consecutively. Meanwhile, Ms. Yanling Chen also won the Top Prize from Sell-Side for the first time in this selection event.
The selection was organized by the Institutional Investor Magazine, and opinions were gathered from more than 860 fund managers of more than 520 buy-side companies as well as 659 analysts from 94 sell-side institutions in Asia (excluding Japan) that has deep influence in Asia. The headquarter of the Institutional Investor Magazine is set in New York, honored as one of the world∮s most influential financial magazine, which mainly offers industry research reports and news analysis for all elite working in the Wall Street and worldwide financial institutions.
Since listed on the Main Board of Hong Kong Stock Exchange, we are always adhering to excellent and effective communication with investors. Awarded with all these honors fully reflects investors’ confidence in the company’s management team as well as in the company’s future healthy development.